Janssen Leiden, Organon Oss (since 1 July 2025), Astellas Leiden — IGJ holds GMP.
Cross-border GMP fit-out workforce mobilisation against Janssen Biologics Leiden, Organon Oss biotech site (transferred from MSD 1 July 2025) and Astellas Pharma Europe Leiden — EU GMP Annex 1 (2022), IGJ inspection, VCCN guidance, KIWA Watermark.
Request Technical BriefingRegulator exposure profile
- EU GMP Annex 1 (2022)32%
- IGJ + VCCN24%
- WagwEU + Wtta (2027)22%
- BPF Bouw + KIWA UPW22%
Pressure-cascade direction is the proof.
EU GMP Annex 1 (2022) positive-pressure cascade A → B → C → D. IGJ (Inspectie Gezondheidszorg en Jeugd) verifies cascade direction at on-site inspections; cleanroom monitoring under ISO 14644-1/-2 and VCCN guidance.
▲ Grade A · +30 Pa
- A fulfilled
Aseptic processing
- +30 Pa target
- ISO Class 5 in-operation
- Microbial < 1 CFU/m³
- B fulfilled
Surrounding Grade A
- +15 Pa target
- ISO Class 7 in-operation
- C partial
Clean preparation
- +5 Pa target
- ISO Class 7 at-rest
- D unfulfilled
Support
- Ambient
- ISO Class 8 at-rest
▼ Grade D · ambient
Named projects in this jurisdiction
- Janssen Biologics Leiden Bio Science Park (new building, construction H1 2026) Johnson & Johnson Innovative Medicine
- Organon Oss biotech site (transferred from MSD 1 July 2025, 278 staff) Organon
- Astellas Pharma Europe Leiden (Sylviusweg 62) Astellas Pharma Europe
The Dutch pharma-manufacturing cluster is concentrated in Leiden (Janssen Biologics, Astellas), Oss (Organon, since 1 July 2025), Weesp (Abbott legacy facility) and Bio Science Park ecosystem. IGJ (Inspectie Gezondheidszorg en Jeugd) is the federal inspection authority.
01. Pre-pricing — CAO Metalektro + CAO Bouw split
Electrical / BMS + chemicals-process scopes sit under CAO Metalektro. Civil shell (cleanroom envelope, raised access floor, EXC3 steel) sits under CAO Bouw & Infra 2025-2027 with BPF Bouw 25.73% pension premium.
02. MeldNL + A1 + EU GMP Annex 1 documentation
A1 + MeldNL filing predate site arrival. The Annex 1 (2022) layer adds the QMS-facing documentation: change-control records, qualification protocols (DQ/IQ/OQ/PQ) routed through the operator’s QA team, and the contamination-control strategy (CCS) interface.
03. BPF Bouw + cleanroom-trade onboarding
Civil-trade portion at BPF Bouw 25.73% from 1 January 2026. Process-trade workforce against CAO Metalektro. The site-access register carries the determining classification.
04. NLA + IGJ-defensible evidence pack
Dual oversight: NLA on workforce-compliance, IGJ on GMP. Minimum survivable pack: SEPA-traceable remuneration, CAO-compliant timesheets, MeldNL submission, BPF Bouw membership, gowning-qualification record per individual, IGJ-recognised CCS file.
05. India and Gulf sourcing corridors — the GMP-trade pathway
Indian pharmaceutical-trade pool delivers IIW-certified WFI-loop welders, BHEL-trained controls engineers, ISPE-affiliated GMP-trained cleanroom-fitters. Gulf corridor is less active for pharma-GMP scope. Anerkenning van Beroepskwalificaties recognition + operator gowning-qualification scheduled into post-arrival window.
The 8 to 14-week corridor delivers the Grade-A-eligible candidate against Janssen Leiden, Organon Oss or Astellas Leiden.